Johnson & Johnson (NYSE: JNJ), fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular (NASDAQ: ITCI), reported fourth-quarter
11 months ago
On Monday, Johnson & Johnson (NYSE: JNJ) said it would buy neurological drug maker Intra-Cellular Therapies (NASDAQ: ITCI) for $14.6
The U.S. Food and Drug Administration is proposing that cosmetic products containing talc should be tested using standardized methods to
12 months ago
Johnson & Johnson (NYSE: JNJ) must pay $15 million to a Connecticut man who alleges that he developed mesothelioma, a
1 year ago
Johnson & Johnson (NYSE: JNJ) raised its 2024 profit and sales forecasts on Tuesday after reporting strong sales of oncology
NEW YORK – A Johnson & Johnson (NYSE: JNJ) subsidiary can pursue its third attempt to resolve tens of thousands
On Tuesday, Johnson & Johnson (NYSE: JNJ) said it will invest more than $2 billion to build a new manufacturing
A Johnson & Johnson (NYSE: JNJ) subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant
A state judge in Oregon has overturned a jury’s $260 million verdict against Johnson & Johnson (NYSE: JNJ) in a
NEW YORK – On Friday, Johnson & Johnson (NYSE: JNJ) said it is negotiating with plaintiffs’ lawyers who have opposed
On Tuesday, the U.S. Food and Drug Administration approved Johnson & Johnson’s (NYSE: JNJ) chemotherapy-free combination treatment for a type
NEW YORK – Johnson & Johnson (NYSE: JNJ) is preparing to unveil widespread support in the coming days for a
